SILO earnings: next report 2026-09-02, real EPS beat/miss history, P/E -0.62. Updated 2026-07-23.
Silo Pharma (SILO) Research Hub
Silo Pharma (SILO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.1 USD (-2.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.62, market cap 0.00B. This hub links to the full technical, earnings and options research available for SILO.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.1 USD (-2.33%) |
| 52-week range | 2.05 USD – 7.95 USD |
| Trend regime | Range |
| 14-day RSI | 2.9 (Oversold) |
| Trailing P/E | -0.62 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for SILO
Covered Call on SILO: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SILO: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SILO: how it works, illustrative setup around the real 2.1 USD price, max profit/loss, breakeven and when to use it. Educational.
SILO technical analysis: range, last 2.1 USD, RSI 2.9, 52w range 2.05 USD–7.95 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SILO in?
Silo Pharma (SILO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SILO in an uptrend or downtrend?
As of 2026-09-11, SILO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SILO's trailing P/E ratio?
SILO's trailing P/E is -0.62, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does SILO next report earnings?
SILO is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of -0.32 USD.